{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:44:24Z","timestamp":1793709864711,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI21\/00208"],"award-info":[{"award-number":["PI21\/00208"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CB16\/12\/00228"],"award-info":[{"award-number":["CB16\/12\/00228"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201060","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:46:37Z","timestamp":1758624397000},"page":"201060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Andrea","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaira","family":"Alberquilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00edn-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Minguill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Esquinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Errazquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Del Marro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Lorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Juarranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barahona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Balma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201060_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185126","article-title":"Deficiency of the Fanconi anemia core complex protein FAAP100 results in severe Fanconi anemia","volume":"135","author":"Harrison","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201060_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00439-022-02462-9","article-title":"Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair","volume":"141","author":"Peake","year":"2022","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omton.2025.201060_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tig.2017.11.006","article-title":"Multifaceted Fanconi Anemia Signaling","volume":"34","author":"Che","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.omton.2025.201060_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111619","article-title":"New Insights into the Fanconi Anemia Pathogenesis: A Crosstalk Between Inflammation and Oxidative Stress","volume":"25","author":"Repczynska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2025.201060_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2017.176131","article-title":"Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia","volume":"103","author":"Bottega","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.201060_bib6","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201060_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI142842","article-title":"Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia","volume":"132","author":"Casado","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201060_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archotol.129.1.106","article-title":"High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia","volume":"129","author":"Kutler","year":"2003","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.omton.2025.201060_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.201060_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201060_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bjh.14615","article-title":"How I manage patients with Fanconi anaemia","volume":"178","author":"Dufour","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201060_bib12","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1002\/cncr.23954","article-title":"Head and neck squamous cell carcinoma in 13 patients with fanconi anemia after hematopoietic stem cell transplantation","volume":"113","author":"Masserot","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib13","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1002\/cncr.32435","article-title":"Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia","volume":"125","author":"Amen\u00e1bar","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41591-019-0550-z","article-title":"Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia","volume":"25","author":"R\u00edo","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.201060_bib15","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0140-6736(24)01880-4","article-title":"Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1\/2 (FANCOLEN-1) and long-term clinical trials","volume":"404","author":"R\u00edo","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.omton.2025.201060_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","article-title":"Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201060_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ijc.34277","article-title":"Oral cancer prediction by noninvasive genetic screening","volume":"152","author":"Poell","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib18","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1158\/1078-0432.CCR-21-1259","article-title":"Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201060_bib19","first-page":"1","article-title":"Post-Operative Clinical Radiosensitivity in Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinomas","volume":"23","author":"Kobilka","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.omton.2025.201060_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201060_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216871","article-title":"The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors","volume":"591","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2025.201060_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-022-05253-4","article-title":"Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer","volume":"612","author":"Webster","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201060_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/PPO.0000000000000623","article-title":"Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer","volume":"28","author":"Bhatia","year":"2022","journal-title":"Cancer J."},{"key":"10.1016\/j.omton.2025.201060_bib24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1245\/s10434-007-9771-3","article-title":"EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases","volume":"15","author":"Wei","year":"2008","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1078-0432.CCR-22-2355","article-title":"Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes","volume":"29","author":"Ge","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201060_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188827","article-title":"EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy","volume":"1878","author":"Kang","year":"2023","journal-title":"Biochim. Biophys. acta. Rev. cancer"},{"key":"10.1016\/j.omton.2025.201060_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fonc.2019.00383","article-title":"Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","volume":"9","author":"Taberna","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2119\/molmed.2011.00493","article-title":"Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells","volume":"18","author":"Davies","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.omton.2025.201060_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/humc.2013.144","article-title":"Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer","volume":"24","author":"Van Schalkwyk","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omton.2025.201060_bib30","doi-asserted-by":"crossref","first-page":"e007162-13","DOI":"10.1136\/jitc-2023-007162","article-title":"Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study","volume":"11","author":"Papa","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib31","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1074\/jbc.M211948200","article-title":"Selective formation of ErbB-2\/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands","volume":"278","author":"Stortelers","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201060_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcyt.2021.11.004","article-title":"Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use","volume":"24","author":"Gotti","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omton.2025.201060_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451404","article-title":"Dual Activation-Induced Marker Combinations Efficiently Identify and Discern Antigen-Specific and Bystander-Activated Human CD4+ T Cells","volume":"55","author":"Ceraolo","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14728222.2018.1444753","article-title":"Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy","volume":"22","author":"Amatore","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.omton.2025.201060_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1378944","article-title":"Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives","volume":"15","author":"Levstek","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201060_bib37","article-title":"CAR-T Cell Performance: How to Improve Their Persistence?","volume":"28","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ejh.14007","article-title":"Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors","volume":"112","author":"Prasongtanakij","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.omton.2025.201060_bib39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-04-3665","article-title":"Generation and Molecular Characterization of Head and Neck Squamous Cell Lines of Fanconi Anemia Patients","volume":"65","author":"Van Zeeburg","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201060_bib40","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.201060_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omton.2025.201060_bib42","first-page":"1632","article-title":"Optimized tandem CD19\/CD20 CAR-engineered T cells in refractory\/relapsed B-cell lymphoma","volume":"136","author":"Tong","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201060_bib43","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.7150\/ijbs.108036","article-title":"From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapy","volume":"21","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omton.2025.201060_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s43018-021-00244-2","article-title":"Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors","volume":"2","author":"Hirabayashi","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/cbt.11.9.15050","article-title":"Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab","volume":"11","author":"Brand","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omton.2025.201060_bib46","first-page":"22","article-title":"Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer","volume":"7","author":"Saleh","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.omton.2025.201060_bib47","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.22.00519","article-title":"Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update","volume":"40","author":"Giordano","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-025-14619-6","article-title":"Opening of a phase Ib\/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma","volume":"25","author":"Anguera","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2025.201060_bib49","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.seminoncol.2014.08.005","article-title":"From monoclonal antibodies to chimeric antigen receptors for the treatment of human malignancies","volume":"41","author":"Caruana","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.2023023419","article-title":"CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis","volume":"144","author":"Kim","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201060_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116532","article-title":"Efficient combination of radiotherapy and CAR-T \u2013 A systematic review","volume":"174","author":"Szlasa","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2025.201060_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.omto.2020.06.016","article-title":"Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia","volume":"18","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2025.201060_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.539654","article-title":"4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1063454","article-title":"Analysis of causes for poor persistence of CAR-T cell therapy in vivo","volume":"14","author":"Kong","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201060_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jmg.2006.044719","article-title":"A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network","volume":"44","author":"Antonio Casado","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omton.2025.201060_bib57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0301-472X(02)00782-8","article-title":"Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool","volume":"30","author":"Hanenberg","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omton.2025.201060_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omton.2025.201060_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201060_bib60","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/2159-8290.CD-20-1661","article-title":"IFN\u03b3 is critical for CAR T cell\u2013mediated myeloid activation and induction of endogenous immunity","volume":"11","author":"Alizadeh","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2025.201060_bib61","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.celrep.2018.04.051","article-title":"Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System","volume":"23","author":"Avanzi","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201060_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/genes12040548","article-title":"Generating new fanca-deficient hnscc cell lines by genomic editing recapitulates the cellular phenotypes of fanconi anemia","volume":"12","author":"Errazquin","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.omton.2025.201060_bib63","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/jcm12062173","article-title":"Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Wang","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omton.2025.201060_bib64","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201060_bib65","article-title":"Use of a universal targeting CAR T cell to simultaneously kill cancer cells and cancer-associated fibroblasts","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201060_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s13402-021-00593-1","article-title":"CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities","volume":"44","author":"Akhoundi","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41571-024-00959-y","article-title":"Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks","volume":"22","author":"Diorio","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201060_bib68","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1002\/acg2.84","article-title":"TRUCKS, the fourth-generation CAR T cells: Current developments and clinical translation","volume":"3","author":"Chmielewski","year":"2020","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.omton.2025.201060_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omton.2025.201060_bib70","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/gt.2010.62","article-title":"Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector","volume":"17","author":"Becker","year":"2010","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:29:35Z","timestamp":1773167375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001298"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201060","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201060"}}